MACCURA BIOTECHNOLOGY CO.LTD Maccura Biotechnology Co.Ltd
Equities
300463
CNE1000020H3
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.57 CNY | +3.63% |
|
+6.80% | -16.59% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Maccura Biotechnology Co., Ltd., formerly Sichuan Maccura Biotechnology Co., Ltd., is a China-based company principally engaged in research, development, manufacture and sales of in-vitro diagnostics products and the sales of in-vitro diagnostic products of foreign brands as an agent. The Company provides hundreds of products which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
12.57
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.59% | 1.03B | |
| -1.09% | 12.72B | |
| -12.53% | 7.5B | |
| +0.45% | 5.48B | |
| -1.37% | 4.61B | |
| +5.16% | 4.47B | |
| -51.93% | 3.28B | |
| +11.34% | 2.71B | |
| -19.05% | 2.02B | |
| -11.07% | 1.74B |
- Stock Market
- Equities
- 300463 Stock
- News Maccura Biotechnology Co.Ltd
- Mega Genomics Braves Market Turbulence with Launch of $34 Million Hong Kong IPO
